WilliamSchubertMezzanotteMD
Pulmonology • West Chester, PACritical Care Medicine, Pleural Disease
Physician
Dr. Mezzanotte is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
275 South Creek Road
West Chester, PA 19382Phone+1 610-296-3642- Is this information wrong?
Education & Training
University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1988 - 1992
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1984 - 1988
Perelman School of Medicine at the University of PennsylvaniaClass of 1984
Certifications & Licensure
PA State Medical License 1985 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 28 citationsEfficacy and safety of budesonide/formoterol pressurized metered-dose inhaler: Randomized controlled trial comparing once- and twice-daily dosing in patients with asthmaWilliam E. Berger, Eugene R Bleecker, L. O'Dowd, Christopher J. Miller, William S. Mezzanotte> ;Allergy and Asthma Proceedings. 2010 Jan 1
- 47 citationsLong-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients.Stephen P. Peters, Bruce M. Prenner, William S. Mezzanotte, Paula Martin, C.D. O'Brien> ;Allergy and Asthma Proceedings. 2008 Aug 8
- 10 citationsBronchodilation of formoterol administered with budesonide: device and formulation effects.Christopher J. Miller, Stephen Senn, William S. Mezzanotte> ;Contemporary Clinical Trials. 2008 Mar 1
- Join now to see all
Press Mentions
- BELLUS Health Appoints William Mezzanotte, MD, MPH to Its Board of DirectorsMarch 24th, 2021
For Maintenance Treatment of Asthma in ChildrenFebruary 16th, 2017
Boehringer Ingelheim Welcomes Central Role of LAMA/LABA Therapy Within 2017 GOLD Strategy for COPDNovember 16th, 2016- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
